[1] Lavoie TN,Lee BH,Nguyen CQ.Current concepts:mouse models of Sjögren's syndrome[J].J Biomed Biotechnol,2011,2011:549107. [2] Szodoray P,Gal I,Barath S,et al.Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines[J].J Rheumatol,2008,37(3):205-212. [3] 牛广华,张艺凡,高玉洁,等.外周血T细胞亚群及IL-17、IL-10在原发性干燥综合征的表达[J].检验医学与临床,2015,12(18):2664-2665. [4] 房星星,路臻豪,汤建平,等.MSCs通过促分泌TGF-β1、IL-6和IL-10抑制干燥综合征患者CD4+T细胞的活化增殖[J].同济大学学报:医学版,2016,37(4):31-35. [5] Heo YJ,Joo YB,Oh HJ.et al.IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+T cell population of rheumatoid arthritis patients[J].Immunol Lett,2010,127(2):150-156. [6] Swierczek M,Izsvák Z,Ivics Z.The Sleeping Beauty transposon system for clinical applications[J].Expert Opin Biol Ther,2012,12(2):139-153. [7] Sabat R,Grütz G,Warszawska K,et al.Biology of interleukin-10[J].Cytokine Growth Factor Rev,2010,21(5):331-344. [8] Schulze-Tanzil G,Zreiqat H,Sabat R,et al.Interleukin-10 and articular cartilage:experimental therapeutical approaches in cartilage disorders[J].Curr Gene Ther,2009,9(4):306-315. [9] Verhenne S,Vandeputte N,Pareyn I,et al.Long-term prevention of congenital thrombotic thrombocytopenic purpura in ADAMTS13 knockout mice by sleeping beauty transposon-mediated gene therapy[J].Arterioscler Thromb Vasc Biol,2017,37(5):836-844. [10] Inoue H,Kishimoto A,Ushikoshi-Nakayama R,et al.Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren's syndrome[J]. J Clin Biochem Nutr,2016,59(2):107-112. [11] Wu G,Wu N,Li T,et al.Total glucosides of peony ameliorates Sjögren's syndrome by affecting Th1/Th2 cytokine balance[J].Exp Ther Med,2016,11(3):1135-1141. [12] Nanke Y,Kobashigawa T,Yago T,et al.Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease:Potential role of Th17oTh1 in the pathogenesis of autoimmune diseases[J].Nihon Rinsho Meneki Gakkai Kaishi,2016,39(5):473-477. [13] Lee SY,Han SJ,Nam SM,et al.Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren Syndrome dry eye patients[J].Am J Ophthalmol,2013,156(2):247-253. [14] Tan X,Sun S,Liu Y,et al.Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome[J].Eye (Lond),2014,28(5):608-613. [15] Lin X,Rui K,Deng J,et al.Th17 cells play a critical role in the development of experimental Sjögren's syndrome[J].Ann Rheum Dis,2015,74(6):1302-1310. [16] Szodoray P,Nakken B,Barath S,et al.Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders[J].Hum Immunol,2013,74(12):1510-1518. [17] Wang K,Shi L,Yu Z,et al.Cyclosporine A suppresses the activation of the Th17 cells in patients with primary sjögren's syndrome[J].Iran J Allergy Asthma Immunol,2015,14(2):198-207. |